![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hovione Farmaciencia S.a. Loures Pt, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Mometasone furoate monohydrate, Process I, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-121 - Rev 03
This Chemical Type CEP, issued on October 23, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2858 associated with this CEP further emphasizes